The Critical Role of Starting Materials & Processes in Advanced Therapies

June 11, 2024

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and gene therapies and what sets them apart from other therapeutics in terms of their processes. Vives also talks about the top characteristics of good starting materials and particular modes of handling logistics. He also delves into correlating a particular donor for a certain patient and shares where he sees the future of cell and gene therapy going.

GUEST BIO

Joaquim Vives, PhD, head of production, advanced therapies, Banc de Sang i Teixits
Joaquim Vives is focused on research and development of advanced therapies. His specialties are GLP/GMP implementation, development of (stem) cell-based & tissue engineering products for regenerative medicine, the design, execution, and analysis of non-clinical studies, production of (stem & immune) cell-base products for clinical use, the study of biomarkers of bone formation, and 3D bioprinting.

MODERATOR BIO

Ben Locwin, vice president of project solutions, Black Diamond Networks
Ben Locwin is a healthcare executive and industry expert. His work has involved bringing new and innovative medical treatments (drug therapies, vaccines and medical devices) to patient populations with unmet needs across a variety of indications and health conditions. He has also worked with investors on the ‘next big things’ in the industry. He has been featured in The Wall Street Journal, Forbes, USA Today, The Associated Press, Axios, NPR, and other top-tier media.